Physician
Fort Smith Hma, LLC
Fort Smith Hma, LLC was paid $2.38M by Medicaid between Jan 2018 and Jan 2019, across 220 billing codes. Its largest line is 99283, emergency room visit (moderate) — 10% of everything it billed.
33Billing provider infoFORT SMITH HMA, LLC
FORT SMITH, AR 72901
FORT SMITH, AR 72901
33aNPI1578555736assigned 08/15/2005
33bProvider typeGeriatric Medicine (Internal Medicine) Physician
28Total paid$2.38M
24GClaims119,874
24DCodes billed220
24AFirst – last monthJan 2018 – Jan 2019
Compared with peers
Next to other Geriatric Medicine (Internal Medicine) Physician providers in Arkansas
Rank by total paid#1 of 5
Median peer was paid$33K
This provider vs. median72×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 118,992 | $2.37M | |
| 2019 | 882 | $7K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 2,729 | 2,606 | $247K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.2% | 1,782 | 1,698 | $172K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 6.4% | 1,508 | 658 | $151K |
| 80053 | Comprehensive metabolic panel | 5.2% | 6,391 | 4,998 | $123K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.0% | 1,205 | 1,106 | $94K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.8% | 822 | 757 | $91K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.0% | 1,301 | 1,125 | $71K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2.2% | 614 | 343 | $53K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.1% | 9,193 | 6,775 | $51K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.1% | 3,961 | 3,213 | $51K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.1% | 819 | 492 | $51K |
| 80047 | 2.0% | 1,742 | 1,546 | $48K |
208 more codes
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 2.0% | 159 | $47K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.8% | 1,034 | $43K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.7% | 1,368 | $40K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.5% | 609 | $36K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 1.5% | 71 | $35K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.4% | 422 | $34K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.4% | 668 | $32K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 511 | $28K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.2% | 241 | $28K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 4,256 | $26K |
| 84484 | <1% | 2,366 | $23K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 180 | $22K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 776 | $21K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 542 | $21K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,953 | $21K |
| 99285 | Emergency room visit (most serious) | <1% | 861 | $20K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 89 | $19K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 163 | $18K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 562 | $17K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 454 | $17K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 452 | $17K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,755 | $15K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,154 | $15K |
| 81025 | <1% | 1,867 | $15K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,144 | $15K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 774 | $15K |
| 70486 | <1% | 125 | $15K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 676 | $15K |
| 87081 | <1% | 1,579 | $14K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,916 | $14K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 81 | $14K |
| 71020 | <1% | 940 | $13K | |
| 71250 | <1% | 163 | $13K | |
| 80050 | General health panel | <1% | 288 | $13K |
| 82378 | <1% | 404 | $13K | |
| 81001 | <1% | 3,736 | $12K | |
| 85014 | <1% | 1,781 | $11K | |
| 80061 | Lipid panel | <1% | 1,557 | $11K |
| 86901 | <1% | 621 | $10K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 79 | $10K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 86 | $10K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,039 | $10K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 46 | $10K |
| 43248 | <1% | 189 | $9K | |
| 85027 | <1% | 1,776 | $9K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 700 | $8K |
| 87077 | <1% | 807 | $8K | |
| 83735 | <1% | 1,376 | $8K | |
| 83880 | <1% | 353 | $7K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 775 | $7K |
| 80081 | <1% | 75 | $7K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 183 | $7K |
| 82962 | <1% | 1,498 | $7K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 79 | $7K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,243 | $7K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 17 | $6K |
| 82553 | <1% | 571 | $6K | |
| 71010 | <1% | 906 | $6K | |
| 73130 | <1% | 188 | $6K | |
| 83690 | <1% | 1,144 | $6K | |
| 82728 | <1% | 572 | $5K | |
| 80074 | <1% | 126 | $5K | |
| 77066 | Tomosynthesis, mammo | <1% | 81 | $5K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 341 | $5K |
| 73030 | <1% | 212 | $5K | |
| 73560 | <1% | 226 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,113 | $5K |
| 87400 | <1% | 365 | $5K | |
| 82150 | <1% | 865 | $5K | |
| 82607 | <1% | 436 | $5K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 539 | $4K |
| 88304 | <1% | 110 | $4K | |
| 84702 | <1% | 403 | $4K | |
| A9578 | Injection, gadobenate dimeglumine (multihance multipack), per ml | <1% | 188 | $4K |
| 72100 | <1% | 198 | $4K | |
| 73630 | <1% | 177 | $4K | |
| 76801 | <1% | 116 | $4K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 195 | $4K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 634 | $4K |
| 73610 | <1% | 216 | $4K | |
| 82565 | <1% | 119 | $4K | |
| 87040 | <1% | 419 | $3K | |
| 73110 | <1% | 141 | $3K | |
| 86900 | <1% | 621 | $3K | |
| 84439 | <1% | 561 | $3K | |
| 86850 | <1% | 535 | $3K | |
| 87186 | <1% | 623 | $3K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 271 | $3K |
| 96367 | <1% | 71 | $3K | |
| 87070 | <1% | 228 | $3K | |
| 83550 | <1% | 438 | $3K | |
| 87430 | <1% | 217 | $2K | |
| 76642 | <1% | 113 | $2K | |
| 73502 | <1% | 78 | $2K | |
| 87807 | <1% | 203 | $2K | |
| 83540 | <1% | 507 | $2K | |
| 83615 | <1% | 334 | $2K | |
| C1769 | Guide wire | <1% | 202 | $2K |
| 82550 | <1% | 554 | $2K | |
| 96376 | <1% | 193 | $2K | |
| 85610 | <1% | 909 | $2K | |
| 86141 | <1% | 189 | $2K | |
| 93971 | <1% | 63 | $2K | |
| 85730 | <1% | 473 | $2K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 73 | $2K |
| 93017 | <1% | 79 | $2K | |
| 83605 | <1% | 219 | $2K | |
| 86762 | <1% | 251 | $2K | |
| 81003 | <1% | 721 | $2K | |
| 82803 | <1% | 140 | $2K | |
| 82105 | <1% | 104 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 31 | $1K |
| 82746 | <1% | 194 | $1K | |
| 86003 | <1% | 14 | $1K | |
| 74000 | <1% | 94 | $1K | |
| 87147 | <1% | 87 | $1K | |
| 87340 | <1% | 267 | $1K | |
| 36600 | <1% | 83 | $1K | |
| 72040 | <1% | 42 | $1K | |
| 88307 | <1% | 34 | $1K | |
| 86300 | <1% | 57 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 929 | $1K |
| 82677 | <1% | 43 | $1K | |
| 82947 | <1% | 245 | $1K | |
| 97001 | <1% | 23 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 133 | $1K |
| 76536 | <1% | 28 | $1K | |
| 73070 | <1% | 47 | $970.92 | |
| 80069 | <1% | 255 | $966.21 | |
| 88312 | <1% | 281 | $962.00 | |
| 82570 | <1% | 401 | $920.54 | |
| 29580 | <1% | 63 | $907.45 | |
| 74018 | <1% | 38 | $896.93 | |
| 93458 | <1% | 17 | $828.20 | |
| 86592 | <1% | 345 | $827.38 | |
| 83883 | <1% | 21 | $822.62 | |
| 90714 | <1% | 119 | $812.00 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 45 | $802.94 |
| 86336 | <1% | 43 | $761.95 | |
| 82248 | <1% | 232 | $757.19 | |
| 71101 | <1% | 24 | $680.40 | |
| 83970 | <1% | 58 | $673.24 | |
| 82043 | <1% | 234 | $659.12 | |
| 85049 | <1% | 93 | $593.62 | |
| 84153 | <1% | 89 | $561.67 | |
| 80076 | <1% | 88 | $548.49 | |
| 84550 | <1% | 193 | $520.54 | |
| 86038 | <1% | 67 | $520.24 | |
| 77080 | <1% | 24 | $504.77 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 14 | $504.00 |
| 85651 | <1% | 202 | $494.16 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 15 | $454.95 |
| 93880 | <1% | 13 | $444.43 | |
| 83655 | <1% | 28 | $436.56 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 433 | $368.90 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,514 | $366.35 |
| 73090 | <1% | 16 | $326.50 | |
| 86803 | <1% | 27 | $325.28 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 194 | $324.72 |
| 84403 | <1% | 17 | $321.83 | |
| 84481 | <1% | 26 | $290.28 | |
| 93923 | <1% | 12 | $288.60 | |
| 76770 | <1% | 14 | $285.47 | |
| 84100 | <1% | 97 | $266.52 | |
| 85379 | <1% | 29 | $261.02 | |
| 84156 | <1% | 123 | $236.25 | |
| 82140 | <1% | 44 | $224.82 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 479 | $214.85 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 272 | $208.80 |
| 87210 | <1% | 30 | $170.80 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 413 | $154.70 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 405 | $152.88 |
| 77065 | Tomosynthesis, mammo | <1% | 15 | $137.92 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 521 | $135.88 |
| 85046 | <1% | 31 | $132.15 | |
| 84703 | <1% | 14 | $128.76 | |
| 87205 | <1% | 41 | $114.13 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,208 | $113.46 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 856 | $108.02 |
| J1335 | Injection, ertapenem sodium, 500 mg | <1% | 16 | $84.96 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 902 | $84.80 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 374 | $70.08 |
| 84132 | <1% | 29 | $45.92 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 864 | $45.39 |
| J0595 | Injection, butorphanol tartrate, 1 mg | <1% | 57 | $43.34 |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | <1% | 49 | $38.92 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 17 | $38.20 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 427 | $18.94 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 172 | $11.95 |
| 85007 | <1% | 16 | $4.92 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 177 | $3.67 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 14 | $0.01 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 14 | $0.01 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 117 | $0.00 |
| 99152 | 0% | 239 | $0.00 | |
| 97161 | 0% | 43 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 12 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 29 | $0.00 |
| 97162 | 0% | 13 | $0.00 | |
| 96415 | 0% | 74 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 155 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 103 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 14 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 361 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 97 | $0.00 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 0% | 18 | $0.00 |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 0% | 12 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.